Becton, Dickinson and Company Q4 2025 Earnings Recap

BD reported a solid Q4 with revenues of $5.9 billion, reflecting a 7% year-over-year increase, while the full year saw record revenues of $21.8 billion, supported by strong organic growth across key segments.

Key Takeaways

• Q4 adjusted diluted EPS increased to $3.96, contributing to a full-year record of $14.40, driven by efficient operations and revenue growth.
• New BD's organic growth accelerated to 4.9%, demonstrating resilience despite pressure from vaccine demand fluctuations and research funding constraints.
• The company returned $2.2 billion to shareholders, including a significant $1 billion share buyback, while announcing its 54th consecutive dividend increase.
• Initiatives to optimize performance include restructuring for commercial excellence, expanding the sales force, and investing $50 million into R&D to drive future innovation and growth.
• BD's robust portfolio and strategic investments position it for continued mid-single-digit growth amidst ongoing market dynamics.